Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist used in the treatment of type 2 diabetes mellitus and obesity
- Manufactured to meet stringent quality control standards.
- Available in bulk quantities to meet global demands.
- Adheres to US FDA, EMA, and WHO-GMP guidelines.
Product application
- • Treatment of type 2 diabetes mellitus
- • Management of obesity and weight loss therapy
- • Research & development in metabolic disorders
Liraglutide is a long-acting GLP-1 analog designed for the management of type 2 diabetes and reduction of cardiovascular risk. Our engineered, yeast-derived version is in the preclinical stage, showcasing potential for enhanced stability and cost-effective production.
Key Benifits
- • State-of-the-Art Manufacturing: Advanced biopharmaceutical production facility.
- • Stringent Quality Control: In-depth analysis to ensure product consistency.
- • Reliable Supply Chain: Efficient logistics for seamless global distribution.
- • Expert Support: Technical and regulatory assistance available.
Specifications
- • Chemical Name: Semaglutide
- • Molecular Formula: C187H291N45O59
- • Molecular Weight: 4113.64 g/mol
- • Appearance: White to off-white powder
- • Storage Conditions: Store at -20°C for long-term stability
Why Choose Us?
- • Advanced Peptide Synthesis - Cutting-edge technology ensures consistent quality.
- • Regulatory Support - Comprehensive documentation for DMF and regulatory submissions.
- • Reliable Supply Chain - Ensuring timely delivery across global markets.
Our trusted partners
